TodaySaturday, June 13, 2026

Lecanemab was clinically effective in the fight against Alzheimer’s disease

May 11, 2023

The scientists concluded that the experimental anti-dementia drug lekanemab is effective in helping patients.

A drug that was developed specifically to fight Alzheimer’s disease has recently been approved and has proven to be clinically effective.

Doctors hope that the drug will help patients restore impaired neuronal functions in the brain. Writes about it Lenta.ru with a link to the journal Neuron.

Lekanemab is based on antibodies that fight the process of degradation of the cognitive functions of the human brain. Most likely, the benefit was achieved by neutralizing the dangerous beta-amyloid protein aggregates in the form of plaques in the brain.

Now experts have managed to determine the structure of the protein. In the near future, it is planned to determine how the human immune system reacts to the drug lekanemab.

Read the Latest World News Today on The Eastern Herald.

Russia Desk

Russia Desk

The Russia Desk leads The Eastern Herald's coverage of Russia, the war in Ukraine, NATO's eastern flank, and the post-Soviet space. The desk has reported continuously on the Russia-Ukraine conflict since its full-scale expansion in February 2022 and verifies through Kremlin statements, NATO briefings.

Leave a Reply